Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence (CASPR): a Multi-center Observational Cohort Study

NCT06398366 is registered in ClinicalTrials.gov with The Cooper Health System as lead sponsor.

NCT NCT06398366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06398366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence (CASPR): a Multi-center Observational Cohort Study
Lead sponsor
The Cooper Health System
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 14, 2022
Completion date
December 31, 2026
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cryptogenic stroke